drugset / Trial / NCT00972426
A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the clinical study is to evaluate the efficacy and safety for Mikelan LA eye drops 2% (once per day) of intra-ocular pressure decreased.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carteolol | Small molecule | 2 % | Topical |
| Subject | Timolol | Other / unclassified | 0.5 % | Topical |
| Background | Latanoprost | Small molecule | — | — |